Projects per year
- 50 - 100 out of 2,056 results
Search results
-
EU
-
A prospective, open label, Phase I first-in-man trial of safety and tolerability of the humanized Clever-1 antibody (Clevegen)
Shetty, S., Adams, D., Rowe, A., Ma, Y. T. & Gough, R.
17/04/17 → 31/01/19
Project: EU
-
H2020_RIA_NANOCOMMONS_CO-ORDINATOR
Valsami-Jones, E., Lynch, I. & Gkoutos, G.
1/01/18 → 30/06/22
Project: EU
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
PAVE - A nanovaccine Approach for the treatment of Pancreatic Cancer
Grand, R., Moss, P. & Stewart, G.
1/10/19 → 31/03/24
Project: EU
-
-
(E-HL): E-Health and Learning
Arvanitis, T., Baber, C., Davies, D. & Khan, K.
23/01/03 → 22/06/04
Project: EU
-
H2020_COLLAB_NEURAM_(CO-ORDINATOR)
Sik, A., Müller, F., Davies, P. & Fossey, J.
1/10/16 → 30/11/22
Project: EU
-
-
-
-
Industry
-
-
Collaborative Studentship-An investigation into the Biochemical Mechanisms of Granulocyte Priming-Relationship to Phosph
Wakelam, M.
1/10/94 → 30/09/97
Project: Industry
-
-
A study of angiogenesis markers in patients with Clear-Cell Renal Cell Carcinoma undergoing therapy with sunitinib: correlations with tumour response and prognosis
Porfiri, E.
22/11/07 → 30/11/10
Project: Industry
-
-
-
-
-
BBSRC - CASE Award Novel Ligands and Binding Modes of Protein Kinases by High Field NMR Spectroscopy.
Overduin, M.
1/10/06 → 30/09/09
Project: Industry
-
Towards a theoretical framework for planning future convergent networks
Constantinou, C. & Arvanitis, T.
1/10/00 → 28/02/02
Project: Industry
-
Measurement of Multipaths in Physical Radion Channels
Constantinou, C. & Arvanitis, T.
BRITISH TELECOMMUNICATIONS PLC
1/08/00 → 31/01/01
Project: Industry
-
COVID19 BMT: A prospective non interventional study to evaluate the role of immune and inflammatory response in recipients of allogeneic haematopoietic stem cell transplantation (SCT) affected by severe COVID19 infection
Bishop, R., Craddock, C. & Jackson, A.
1/08/20 → 31/12/25
Project: Industry
-
Defining the Metabolic Phenotype of Glial Tumours
Tennant, D. & Cruickshank, G.
1/10/12 → 30/09/16
Project: Industry
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
Jackson, A., Fox, S. & Craddock, C.
3/12/21 → 30/06/26
Project: Industry
-
Application of Fault Tolerant Strategies for Vehicle Systems
Roberts, C. & Arvanitis, T.
1/10/03 → 30/09/06
Project: Industry
-
Genetic Approaches to Novel Pathway and Target Discovery in Human Disease Gen 001 CAF 13_0419
Maher, E.
1/08/14 → 31/07/17
Project: Industry
-
-
LAG3 expression in AIH, PBC, PSC compared with other liver diseases
1/10/19 → 31/03/21
Project: Industry
-
Glo-BNHL: Regeneron Collaboration - A Global Study Of Novel Agents In Relapsed And Refractory B-Non Hodgkin Lymphoma (B-NHL)
Kearns, P., Billingham, L., Maycock, S., Holt, G. & Siddique, S.
1/07/23 → 30/06/28
Project: Industry
-
A Phase III Extension Study To Evaluate The Safety Of 10mg Atrasentan In Men With Hormone-Refractory Prostate Cancer.
1/01/02 → 31/12/05
Project: Industry
-
A Double Blind Randomised Placebo Controlled Multi CentreTrial To Evaluate The Efficacy And Safety Of Two Doses...
Bramhall, S. & Adams, D.
BRITISH BIOTECH PHARMACEUTICALS LTD
1/03/97 → 31/10/99
Project: Industry
-
Non-invasive genomic profiling of bladder cancer using urinary cfDNA
1/03/16 → 30/11/16
Project: Industry
-
NOSTRA-Feasibility study: A prospective non-randomised multi-centre feasibility study to assess if patients with residual cancer following dual-targeted neoadjuvant chemotherapy treatment for HER2-positive, ER-negative early breast cancer..
Pirrie, S., Rea, D., Gaunt, C. & Billingham, L.
1/01/18 → 31/12/25
Project: Industry
-
Cytoxic activity of the novel cdk inhibitor, AZ12580005 in chronic lymphocytic leukaemia
1/01/08 → 31/12/08
Project: Industry